Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for treatment of hepatopulmonary syndrome in cirrhosis
2010-023366-49Phase 2Terminated
- Sponsor
- Medical University of Vienna
- Start
- Jun 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hepatopulmonary syndrome (HPS) and Cirrhosis comparing Bosentan (Tracleer) with Placebo (2 arms). Primary endpoints: Primary efficacy and safety of bosentan and Safety and tolerability of bosentan. Started Jun 2011; status: terminated.
02
Drugs
bosentan
03
Conditions
hepatopulmonary syndrome (HPS)Cirrhosis
Beyond the preview
Go deeper on 2010-023366-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023366-49.